JP2015528479A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528479A5 JP2015528479A5 JP2015531580A JP2015531580A JP2015528479A5 JP 2015528479 A5 JP2015528479 A5 JP 2015528479A5 JP 2015531580 A JP2015531580 A JP 2015531580A JP 2015531580 A JP2015531580 A JP 2015531580A JP 2015528479 A5 JP2015528479 A5 JP 2015528479A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- aminophenyl
- acetyl
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 52
- 150000003839 salts Chemical class 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 34
- DQUOOKMLOSPCLZ-UHFFFAOYSA-N 3-(4-acetamidophenyl)-2-methoxypropanoic acid Chemical compound COC(C(O)=O)CC1=CC=C(NC(C)=O)C=C1 DQUOOKMLOSPCLZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 10
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 claims description 8
- 210000003780 hair follicle Anatomy 0.000 claims description 8
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 claims description 8
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 claims description 8
- 210000000130 stem cell Anatomy 0.000 claims description 8
- 201000004384 Alopecia Diseases 0.000 claims description 6
- 231100000360 alopecia Toxicity 0.000 claims description 6
- 230000008929 regeneration Effects 0.000 claims description 6
- 238000011069 regeneration method Methods 0.000 claims description 6
- 230000037390 scarring Effects 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- ICPWFHKNYYRBSZ-UHFFFAOYSA-N 2-methoxypropanoic acid Chemical compound COC(C)C(O)=O ICPWFHKNYYRBSZ-UHFFFAOYSA-N 0.000 claims description 4
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 4
- 208000001126 Keratosis Diseases 0.000 claims description 4
- 206010052428 Wound Diseases 0.000 claims description 4
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- 229960002227 clindamycin Drugs 0.000 claims description 4
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims description 4
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims description 4
- 229960003722 doxycycline Drugs 0.000 claims description 4
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 claims description 4
- XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 claims description 4
- 229960004171 hydroxychloroquine Drugs 0.000 claims description 4
- RTGDFNSFWBGLEC-SYZQJQIISA-N mycophenolate mofetil Chemical compound COC1=C(C)C=2COC(=O)C=2C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1 RTGDFNSFWBGLEC-SYZQJQIISA-N 0.000 claims description 4
- 229960004866 mycophenolate mofetil Drugs 0.000 claims description 4
- 229960005095 pioglitazone Drugs 0.000 claims description 4
- 239000011148 porous material Substances 0.000 claims description 4
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 claims description 4
- 229960001225 rifampicin Drugs 0.000 claims description 4
- 229960004586 rosiglitazone Drugs 0.000 claims description 4
- 229940063673 spermidine Drugs 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 230000029663 wound healing Effects 0.000 claims description 3
- 208000006926 Discoid Lupus Erythematosus Diseases 0.000 claims description 2
- 206010072170 Skin wound Diseases 0.000 claims description 2
- 208000002847 Surgical Wound Diseases 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 claims description 2
- 208000011830 chronic cutaneous lupus erythematosus Diseases 0.000 claims description 2
- 208000004921 cutaneous lupus erythematosus Diseases 0.000 claims description 2
- 230000035617 depilation Effects 0.000 claims description 2
- 230000003325 follicular Effects 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 201000011486 lichen planus Diseases 0.000 claims description 2
- 231100000241 scar Toxicity 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 claims description 2
- 238000007920 subcutaneous administration Methods 0.000 claims description 2
- 230000008733 trauma Effects 0.000 claims description 2
- DQUOOKMLOSPCLZ-NSHDSACASA-N (2s)-3-(4-acetamidophenyl)-2-methoxypropanoic acid Chemical compound CO[C@H](C(O)=O)CC1=CC=C(NC(C)=O)C=C1 DQUOOKMLOSPCLZ-NSHDSACASA-N 0.000 claims 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- DQUOOKMLOSPCLZ-LLVKDONJSA-N (2r)-3-(4-acetamidophenyl)-2-methoxypropanoic acid Chemical compound CO[C@@H](C(O)=O)CC1=CC=C(NC(C)=O)C=C1 DQUOOKMLOSPCLZ-LLVKDONJSA-N 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261700623P | 2012-09-13 | 2012-09-13 | |
| US61/700,623 | 2012-09-13 | ||
| PCT/EP2013/069062 WO2014041140A1 (en) | 2012-09-13 | 2013-09-13 | Methods of treating hair related conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015528479A JP2015528479A (ja) | 2015-09-28 |
| JP2015528479A5 true JP2015528479A5 (https=) | 2016-11-04 |
Family
ID=49170707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015531580A Pending JP2015528479A (ja) | 2012-09-13 | 2013-09-13 | 毛に関連した状態を処置する方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US20150250749A1 (https=) |
| EP (1) | EP2895160B1 (https=) |
| JP (1) | JP2015528479A (https=) |
| KR (1) | KR20150054934A (https=) |
| CN (1) | CN104837486A (https=) |
| AU (1) | AU2013314288B2 (https=) |
| BR (1) | BR112015005467A2 (https=) |
| CA (1) | CA2883823A1 (https=) |
| CY (1) | CY1120793T1 (https=) |
| DK (1) | DK2895160T3 (https=) |
| EA (1) | EA035986B1 (https=) |
| ES (1) | ES2675169T3 (https=) |
| HR (1) | HRP20181000T1 (https=) |
| HU (1) | HUE037903T2 (https=) |
| IL (1) | IL237449A0 (https=) |
| IN (1) | IN2015DN02104A (https=) |
| LT (1) | LT2895160T (https=) |
| MX (1) | MX356888B (https=) |
| NZ (1) | NZ705389A (https=) |
| PL (1) | PL2895160T3 (https=) |
| PT (1) | PT2895160T (https=) |
| SI (1) | SI2895160T1 (https=) |
| TR (1) | TR201809219T4 (https=) |
| UA (1) | UA116215C2 (https=) |
| WO (1) | WO2014041140A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| WO2010091894A2 (en) | 2009-02-16 | 2010-08-19 | Giuliani International Limited | Methods of treating hair related conditions |
| CN109999017A (zh) | 2012-02-09 | 2019-07-12 | 诺格拉制药有限公司 | 治疗纤维化的方法 |
| CN104284655B (zh) | 2012-04-18 | 2017-10-27 | 诺格拉制药有限公司 | 治疗乳糖不耐受的方法 |
| EP4495101A3 (en) | 2019-02-08 | 2025-04-30 | Nogra Pharma Limited | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof |
| TW202541791A (zh) * | 2023-12-20 | 2025-11-01 | 愛爾蘭商諾格拉製藥有限公司 | 痤瘡局部用調配物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010091894A2 (en) * | 2009-02-16 | 2010-08-19 | Giuliani International Limited | Methods of treating hair related conditions |
| CN104284655B (zh) * | 2012-04-18 | 2017-10-27 | 诺格拉制药有限公司 | 治疗乳糖不耐受的方法 |
-
2013
- 2013-09-13 AU AU2013314288A patent/AU2013314288B2/en not_active Ceased
- 2013-09-13 BR BR112015005467A patent/BR112015005467A2/pt active Search and Examination
- 2013-09-13 SI SI201331087T patent/SI2895160T1/sl unknown
- 2013-09-13 JP JP2015531580A patent/JP2015528479A/ja active Pending
- 2013-09-13 HU HUE13762485A patent/HUE037903T2/hu unknown
- 2013-09-13 WO PCT/EP2013/069062 patent/WO2014041140A1/en not_active Ceased
- 2013-09-13 IN IN2104DEN2015 patent/IN2015DN02104A/en unknown
- 2013-09-13 UA UAA201503407A patent/UA116215C2/uk unknown
- 2013-09-13 PT PT137624854T patent/PT2895160T/pt unknown
- 2013-09-13 ES ES13762485.4T patent/ES2675169T3/es active Active
- 2013-09-13 NZ NZ705389A patent/NZ705389A/en not_active IP Right Cessation
- 2013-09-13 LT LTEP13762485.4T patent/LT2895160T/lt unknown
- 2013-09-13 KR KR1020157009052A patent/KR20150054934A/ko not_active Withdrawn
- 2013-09-13 EP EP13762485.4A patent/EP2895160B1/en active Active
- 2013-09-13 US US14/428,164 patent/US20150250749A1/en not_active Abandoned
- 2013-09-13 TR TR2018/09219T patent/TR201809219T4/tr unknown
- 2013-09-13 CN CN201380047941.4A patent/CN104837486A/zh active Pending
- 2013-09-13 CA CA2883823A patent/CA2883823A1/en not_active Abandoned
- 2013-09-13 EA EA201590546A patent/EA035986B1/ru not_active IP Right Cessation
- 2013-09-13 HR HRP20181000TT patent/HRP20181000T1/hr unknown
- 2013-09-13 DK DK13762485.4T patent/DK2895160T3/en active
- 2013-09-13 MX MX2015003278A patent/MX356888B/es active IP Right Grant
- 2013-09-13 PL PL13762485T patent/PL2895160T3/pl unknown
-
2015
- 2015-02-26 IL IL237449A patent/IL237449A0/en unknown
-
2018
- 2018-06-28 CY CY20181100673T patent/CY1120793T1/el unknown
-
2020
- 2020-06-04 US US16/892,513 patent/US20210113505A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015528479A5 (https=) | ||
| JP2013524856A5 (https=) | ||
| JP2012508750A5 (https=) | ||
| MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
| RU2013108394A (ru) | Соединения и способы восстановления кожи | |
| JP2014503586A (ja) | 油組成物 | |
| MX2011010859A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2002532432A5 (https=) | ||
| NZ586302A (en) | Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising | |
| CY1120793T1 (el) | Μεθοδοι θεραπευτικης αγωγης παθησεων που αφορουν μαλλια | |
| RU2013132566A (ru) | Терапевтическое средство от грыжи межпозвоночного диска | |
| RU2016106829A (ru) | Применение ингибиторов ацетил-СоА карбоксилазы для лечения обыкновенных угрей | |
| JP2022541572A5 (https=) | ||
| KR20140012651A (ko) | 파라벤 조성물 | |
| KR20130119958A (ko) | 피부 회복을 위한 조성물 및 방법 | |
| Chivukula et al. | The early days of hemostasis in neurosurgery | |
| KR20190038840A (ko) | 피부 및/또는 모발 복구를 위한 5-하이드록시트립타민 1b 수용체-자극제 | |
| JP2013520447A5 (https=) | ||
| DK2004235T3 (da) | Sammensætning til kosmetisk eller farmaceutisk-dermatologisk anvendelse | |
| WO2006088945A3 (en) | Granulysin peptides and methods of use thereof | |
| Braun | Comparison of high-fluence, single-pass diode laser to low-fluence, multiple-pass diode laser for laser hair reduction with 18 months of follow up | |
| WO2016081296A3 (en) | Topical medicament for skin and mucosal injuries associated with epidermolisis bullosa | |
| WO2012075244A3 (en) | Use of hemoglobin effectors to increase the bioavailability of therapeutic gases | |
| JP2014501242A5 (https=) |